Dr. Qianwen Liu 刘乾文
Chief Physician
Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, minimally invasive surgery, and comprehensive treatment for lung nodules, lung cancer, esophageal cancer, and mediastinal tumors. Techniques include thoracoscopy, laparoscopy, and video mediastinoscopy.
Dr. Liu is a Chief Physician and Professor at Sun Yat-sen University Cancer Center, holding a PhD in Oncology. Since 2009, Dr. Liu has specialized in minimally invasive thoracic surgery. Research focuses on VAMLA for lung cancer staging and non-thoracotomy esophagectomy. Dr. Liu has published over 20 SCI papers and leads provincial research projects.
Professional roles
- Member, Mediastinal Tumor Committee, China Anti-Cancer Association
- Member and Secretary, Esophageal Cancer Committee, Guangdong Anti-Cancer Association
- Leader, Esophageal Tumor Group, Oncologic Surgery Branch, Guangdong Medical Doctor Association
- Standing Committee Member, Oncologic Surgery Branch, Guangdong Medical Doctor Association
Name order: in Chinese the family name comes first (Liu Qianwen). Papers usually list the name as Qianwen Liu or Liu Q.
Selected publications
86 papers on PubMed matched by name and affiliation; 11 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Transl Med, 2026 (senior author): METTL13 mediated SAA1 translation maintains cancer stem cell behavior and promotes esophageal carcinoma progression. PubMed 41764490
- Dis Esophagus, 2025 (senior author): Characteristics analyses and tumor staging proposal for primary malignant melanoma of the esophagus: a retrospective study. PubMed 39970075
- Ann Med, 2024 (senior author): Nomograms for predicting the prognosis in multiple primary esophageal squamous cell carcinoma. PubMed 39623769
- Int J Surg, 2023 (senior author): Analysis of prognostic factors and establishment of prognostic model for primary mediastinal germ cell tumors: a case controlled study. PubMed 37222675
- Front Oncol, 2022 (senior author): Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis. PubMed 36591498
- Front Oncol, 2022 (senior author): A Nomogram Model to Predict Post-Progression Survival in Esophageal Squamous Cell Carcinoma Patients With Recurrence After Radical Resection. PubMed 35875105
- Esophagus, 2021 (senior author): The characteristics and prognostic significance of esophageal squamous cell carcinoma with synchronous multiple lesions: over 10-year experience. PubMed 34110538
- J Thorac Dis, 2017 (first author): Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma. PubMed 29268525
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion